VISFO
Resources
Resource area
Tool and strategies modern teams need to help their companies grow.
How Medical Affairs can navigate conflicting priorities
If you’ve worked in Medical Affairs for more than five minutes, you’ve already faced the alignment problem.
Read post
How dynamic scientific ranking changes everything
Every strategic decision in pharma depends on having the right information at the right time, however, the volume and fragmentation of scientific data can make that incredibly difficult.
Read post
VISFO teams up with Oncology Access Solutions to offer insights on CAR T-cell therapies
Planning the road ahead: why a modified approach to developing a Target Product Profile (TPP) is essential
Read post
Three reasons Rising Stars are the key to future-proofing your medical strategy
What if you could engage with emerging thought leaders before they become the next big thing? Shifting your focus could transform how you build influence and future-proof your medical strategy.
Read post
.png)
A day in the life of a PhD student, with Jadie Acklam
Meet Jadie, a University of York PhD student who is part of our wider relationship with the University of York. Jadie took us along for a day in her life working within the Haematology Malignancy Diagnostic Services at St James's University Hospital.
Read post
AI's role in transforming patient care: Perspectives from our Principal Product Manager
We sat down with our Principal Product Manager, Dr Rachael Hagan, to chat about her role at VISFO and her thoughts on the impact of AI on patient care and her insights into the future of the field.
Read post
.png)
MAPS 2024 Americas Annual Meeting
Join VISFO at Booth 508 at MAPS 2024 to experience iGen, our new insight management solution that turns data into actionable insights. Don’t miss a live demo with President Carol Heggie!
Read post
VISFO unveils its effortless insight management platform at MAPS, launching iGen
VISFO is launching iGen, an intuitive insight management platform, at MAPS Puerto Rico. Visit Booth 508 for a demo and discover how iGen drives Medical Affairs strategy, effortlessly.
Read post
How I became James Iremonger, Head of Data Science at VISFO
Meet James, our Head of Data Science and one of the longest-serving members of the VISFO team. We had a chat with James about his journey to becoming a Data Scientist, his top tips for entering the industry, and the biggest challenges of the job.
Read post
Building a brighter future with patient support programmes
We explore how patient support programmes (or PSPs) are bridging the gap between pharma, healthcare professionals and patients.
Read post
Insight to impact: How insights are shaping Medical Affairs strategies
We look at how Medical Affairs teams are adapting to changing data landscapes.
Read post
Looking to the future of patient empowerment
Empowering health journeys starts with seeing patients as people, not just conditions.
Read post
VISFO invests in a new brand as it continues to grow its client base in the US and Europe
A healthtech consultancy based in West Yorkshire is taking the pharmaceutical (pharma) industry by storm, revealing a new brand direction for 2022.
Read post
VISFO kicks off Enigma scholarships at University of York
VISFO successfully launches its scholarship programme at the University of York.
Read post
VISFO sees exponential growth as demand from pharma clients soars
VISFO accelerates growth with soaring demand for digital insights and software solutions, tripling its client base and expanding its global footprint.
Read post
Reflections on Web Summit 2023
We catch up with Andy Hall, our Chief Product Officer about his trip to Web Summit 2023, all things AI and what this means for the future.
Read post
Digital transformation and medical affairs: How do the two marry up?
There’s no way around it – to realise its true strategic value, medical affairs needs to go digital. But what does that even mean? And what exactly can digital transformation deliver?
Read post
Pick up the phone: A post-pandemic look at the potential role of mHealth tools in lupus care
We look at what we can learn from the patient experience and how mHealth technologies might soon provide tangible solutions to problems surfaced by COVID-19.
Read post
The value of good design
We catch up with our UX researcher, Lily about the value of good design and everything her and the team learnt at the Tech Circus Business X Design Conference.
Read post
.png)
Mapping patient pathways… Has anyone asked the patient?
Patients should be at the heart of charting patient pathways, but to achieve this we need to look to novel ways to engage with them.
Read post
A day in the life of a Data Scientist, with Dr Adam Poulston
We catch up with Adam, our head of Natural Language Processing and Machine Learning, about what it’s like at VISFO, his journey into the role, and his favorite part of the job!
Read post
Adjusting to the Fourth Industrial Revolution
How VISFO is reacting to the new normal and seeing opportunity to thrive.
Read post
Let’s talk lupus: DLA summit highlights
We catch up with Filsane Haji about the Digital Lupus Advocacy Summit to talk about what she learnt and how she is excited to incorporate that into her work here at VISFO.
Read post
So good, it was BAD
We talk to our Behavioral Scientist, Lily Parsons, about how she’s settling into her new role at VISFO, the psychology behind user-based research, and her recent attendance at The BAD Conference.
Read post
VISFO widens participation with a new scholarship programme for undergraduate students at York
Introducing the Enigma programme for students from widening participation backgrounds.
Read post
Thinking about the future of healthcare
VISFO’s Chief Medical Officer, Dr. David Williams, reflects on the need for patient centricity in the development of health technology.
Read post
Understanding market opportunities to create compelling product value communications
Understanding market opportunity to effectively communicate its early value proposition to various stakeholders.
Read post
Strategic design of a Phase 3 clinical trial to maximize the likelihood of treatment approval
Maximizing the likelihood of becoming a standard-of-care therapy.
Read post
Bridging epidemiological data gaps to inform prospective commercial appeal
Understanding the probable success of various launch indications.
Read post
Elevating a competitive communication strategy through data-driven analysis in a novel therapeutic field
Topic modeling to support a digital first approach.
Read post
Optimizing clinical trial performance: A comprehensive analysis and strategic roadmap
Empowering our client to formulate an impactful trial strategy.
Read post
Unlocking market insights: Bridging data gaps to inform Phase 3 trial strategy and beyond
Clinical landscaping for strategic market positioning.
Read post
Discovering novel and adjunct indications to support market expansion of an established supplement
Finding new indications through a comprehensive scientific appraisal.
Read post
Maximizing ROI: Strategic recommendations for an impactful conference
Conference listening and insights to increase share of scientific voice.
Read post
Cut through the noise: Analyzing digital landscapes following FDA approval
Key Opinion Leader (KOL) and Digital Opinion Leader (DOL) identification through an in-depth digital analysis.
Read post
Assessing commercial opportunity through a robust statistical analysis of sexual health product reviews
An unbiased product quality assessment of a potential manufacturer.
Read post
Scientific landscaping to discover novel indications for potential market expansion
Discovering novel indications to inform the potential market expansion and claims of an over-the-counter (OTC) supplement.
Read post
Enhancing strategic decision-making: An acquisition case study
A diligence exercise on the potential resource requirement of a prospective commercial asset.
Read post